Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S5 from A Phase II, Open-label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non–Hodgkin Lymphoma
  1. Home
  2. Publications
  3. Figure S5 from A Phase II, Open-label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non–Hodgkin Lymphoma

Figure S5 from A Phase II, Open-label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non–Hodgkin Lymphoma

Authors:
  • JDJustin M. Darrah
    Justin M. Darrah
  • IVIndumathy Varadarajan
    Indumathy Varadarajan
  • AMAmitkumar Mehta
    Amitkumar Mehta
  • JSJennifer N. Saultz
    Jennifer N. Saultz
  • MMMatthew S. McKinney
    Matthew S. McKinney
  • MGMonalisa Ghosh
    Monalisa Ghosh
  • UGUsama Gergis
    Usama Gergis
  • AKAndrew Krueger
    Andrew Krueger
  • KGKevin J. Galinsky
    Kevin J. Galinsky
  • GBGirish Bende
    Girish Bende
  • ARAjeetha Ramachandran
    Ajeetha Ramachandran
  • VSVarsha Sundaresan
    Varsha Sundaresan

Open Access
Publisher website
Google Scholar
  • 3 November 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2643-3230.34898239
Abstract
Supplementary Figure S5 shows differential gene expression in Day 0 samples that did versus did not elicit a clinical response, based on pseudobulk analysis.
Keywords
  • HEMATOLOGICAL CANCERS
  • LYMPHOMAS
  • IMMUNOLOGY
  • NK CELLS
  • IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.